Products for Research Use Only

QNX-10

CAT: 0804-HY-175020Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-175020Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
QNX-10 is a fatty acid synthase (FASN) inhibitor (IC50 = 0.7 μM) with anticancer activity. QNX-10 exhibits potent FASN inhibition and cytotoxicity against colorectal and breast cancer cells. QNX-10 induces apoptosis and cell cycle arrest in S phase by upregulating the pro-apoptotic protein Bax and downregulating the anti-apoptotic protein Bcl-xL. QNX-10 can be used to investigate anticancer therapies targeting FASN enzymes[1].
UNSPSC
12352005
Target
Apoptosis; Bcl-2 Family; Fatty Acid Synthase (FASN)
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
FC1=CC=C(C2=CN=C(C=C(C(N3CCN(C(C4OCCC4)=O)CC3)=O)C=C5)C5=N2)C=C1
Molecular Formula
C24H23FN4O3
Molecular Weight
434.46
References & Citations
[1]Singh S, et al. Design, synthesis and biological evaluation of 2-phenylquinoxaline carbonyl piperazine derivatives as novel FASN inhibitors with anticancer activity. Bioorg Chem. 2025 Jun 21;163:108697.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Bax; Bcl-xL

Popular Products